J. W. J. Bijlsma

52.2k total citations · 6 hit papers
506 papers, 28.8k citations indexed

About

J. W. J. Bijlsma is a scholar working on Rheumatology, Surgery and Hematology. According to data from OpenAlex, J. W. J. Bijlsma has authored 506 papers receiving a total of 28.8k indexed citations (citations by other indexed papers that have themselves been cited), including 346 papers in Rheumatology, 75 papers in Surgery and 58 papers in Hematology. Recurrent topics in J. W. J. Bijlsma's work include Rheumatoid Arthritis Research and Therapies (224 papers), Osteoarthritis Treatment and Mechanisms (113 papers) and Systemic Lupus Erythematosus Research (101 papers). J. W. J. Bijlsma is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (224 papers), Osteoarthritis Treatment and Mechanisms (113 papers) and Systemic Lupus Erythematosus Research (101 papers). J. W. J. Bijlsma collaborates with scholars based in Netherlands, United States and Germany. J. W. J. Bijlsma's co-authors include Floris P. J. G. Lafeber, Johannes W. G. Jacobs, Francis Bérenbaum, Joost Dekker, Rinie Geenen, F.P.J.G. Lafeber, Joël A. G. van Roon, Floris W. Kraaimaat, Jeroen DeGroot and R.A.B. Oostendorp and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

J. W. J. Bijlsma

496 papers receiving 27.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Osteoarthritis: an update with relevance for clinical practice

2011 1.7k citations J. W. J. Bijlsma, Floris P. J. G. Lafeber et al. profile →
Effect of Collagen Turnover on the Accumulation of Advanced Glycation End Products

2000 704 citations Nicole Verzijl, Jeroen DeGroot et al. profile →
Beyond unfavorable thinking: The Illness Cognition Questionnaire for chronic diseases.

2001 513 citations Johannes W. G. Jacobs, J. W. J. Bijlsma et al. profile →
Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

2004 512 citations L.B.A. van de Putte, Catherine Atkin et al. Annals of the Rheumatic Diseases profile →
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis

2020 195 citations Alexandre Sepriano, Andreas Kerschbaumer et al. Annals of the Rheumatic Diseases profile →
2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis

2021 171 citations J. W. J. Bijlsma et al. Annals of the Rheumatic Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. W. J. Bijlsma Netherlands	89	15.0k	5.1k	4.0k	3.9k	3.4k	506	28.8k
Sherine E. Gabriel United States	76	16.4k 1.1×	5.3k 1.0×	4.1k 1.0×	3.2k 0.8×	2.3k 0.7×	202	29.3k
Tore K Kvien Norway	84	18.4k 1.2×	3.8k 0.7×	5.5k 1.4×	5.4k 1.4×	4.4k 1.3×	537	28.6k
Philip G. Conaghan United Kingdom	93	24.0k 1.6×	8.4k 1.6×	3.6k 0.9×	5.0k 1.3×	4.4k 1.3×	742	34.3k
Matthew H. Liang United States	62	19.8k 1.3×	6.9k 1.3×	5.4k 1.4×	4.9k 1.3×	3.7k 1.1×	193	37.3k
Jennifer J. Anderson United States	62	10.0k 0.7×	4.2k 0.8×	1.4k 0.4×	3.0k 0.8×	2.4k 0.7×	132	21.8k
Charles G. Helmick United States	61	11.8k 0.8×	6.0k 1.2×	2.0k 0.5×	1.5k 0.4×	4.7k 1.4×	193	24.2k
Gene G. Hunder United States	77	30.3k 2.0×	5.6k 1.1×	6.7k 1.7×	4.6k 1.2×	2.2k 0.6×	217	49.4k
Steven B. Abramson United States	89	11.0k 0.7×	4.5k 0.9×	4.6k 1.2×	1.4k 0.4×	7.5k 2.2×	309	29.9k
Alan J. Silman United Kingdom	104	11.5k 0.8×	8.4k 1.6×	4.3k 1.1×	2.8k 0.7×	7.8k 2.3×	424	46.4k
Cynthia S. Crowson United States	87	13.7k 0.9×	4.7k 0.9×	4.3k 1.1×	2.7k 0.7×	618 0.2×	476	28.1k

Countries citing papers authored by J. W. J. Bijlsma

Since Specialization

Citations

This map shows the geographic impact of J. W. J. Bijlsma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. W. J. Bijlsma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. W. J. Bijlsma more than expected).

Fields of papers citing papers by J. W. J. Bijlsma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. W. J. Bijlsma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. W. J. Bijlsma. The network helps show where J. W. J. Bijlsma may publish in the future.

Co-authorship network of co-authors of J. W. J. Bijlsma

This figure shows the co-authorship network connecting the top 25 collaborators of J. W. J. Bijlsma. A scholar is included among the top collaborators of J. W. J. Bijlsma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. W. J. Bijlsma. J. W. J. Bijlsma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Qiuke, J. Runhaar, M. Kloppenburg, et al.. (2022). Diagnosis for early stage knee osteoarthritis: probability stratification, internal and external validation; data from the CHECK and OAI cohorts. Seminars in Arthritis and Rheumatism. 55. 152007–152007. 11 indexed citations

Kerschbaumer, Andreas, Alexandre Sepriano, Josef S Smolen, et al.. (2020). Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis. Annals of the Rheumatic Diseases. 79(6). 744–759. 188 indexed citations

Bijlsma, J. W. J.. (2019). Het voorwaardelijk sepot : normering, praktijk, evaluatie. Data Archiving and Networked Services (DANS).

Lübbers, Joyce, Marian H. van Beers-Tas, Saskia Vosslamber, et al.. (2016). Changes in peripheral blood lymphocyte subsets during arthritis development in arthralgia patients. Arthritis Research & Therapy. 18(1). 205–205. 33 indexed citations

Lübbers, Joyce, Samina A. Turk, Saskia Vosslamber, et al.. (2016). The type I interferon signature in leukocyte subsets from peripheral blood of patients with early arthritis: a major contribution by granulocytes. Arthritis Research & Therapy. 18(1). 165–165. 27 indexed citations

Klop, C., Deborah Gibson-Smith, Petra J. M. Elders, et al.. (2015). Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000–2010. Osteoporosis International. 26(7). 1919–1928. 68 indexed citations

Drossaert, Constance H.C., et al.. (2015). Feasibility of a Website and a Hospital-Based Online Portal for Young Adults With Juvenile Idiopathic Arthritis: Views and Experiences of Patients. SHILAP Revista de lepidopterología. 4(3). e102–e102. 16 indexed citations

Goes, Marlies C. van der, J. W. G. Jacobs, Tim Andrews, et al.. (2013). EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases. Annals of the Rheumatic Diseases. 72(12). 1905–1913. 180 indexed citations

DeGroot, Jeroen, et al.. (2012). Elevation of cartilage AGEs does not accelerate initiation of canine experimental osteoarthritis upon mild surgical damage. Journal of Orthopaedic Research®. 30(9). 1398–1404. 19 indexed citations

10.

Zweers, Manon C., T.N. de Boer, Joël van Roon, et al.. (2011). Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis. Arthritis Research & Therapy. 13(5). 239–239. 94 indexed citations

11.

Schett, Georg, Kenneth G. Saag, & J. W. J. Bijlsma. (2010). From bone biology to clinical outcome: state of the art and future perspectives. Annals of the Rheumatic Diseases. 69(8). 1415–1419. 68 indexed citations

12.

Bakker, Marije F., J. W. G. Jacobs, Suzanne Verstappen, & J. W. J. Bijlsma. (2008). Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility (vol 66, pg 56, 2007). Annals of the Rheumatic Diseases. 67(1). 1 indexed citations

13.

Hoes, Jos N., Johannes W. G. Jacobs, Maarten Boers, et al.. (2007). EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Annals of the Rheumatic Diseases. 66(12). 1560–1567. 281 indexed citations

14.

Jacobs, Johannes W G, R. N. J. de Nijs, Willem F. Lems, et al.. (2007). Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.. University of Groningen research database (University of Groningen / Centre for Information Technology). 34(5). 1051–7. 25 indexed citations

15.

Bijlsma, J. W. J., Alfonse T. Masi, Rainer H. Straub, Robert G. Lahita, & Maurizio Cutolo. (2006). Neuroendocrine Immune System Involvement in Rheumatology. Annals of the New York Academy of Sciences. 1069(1). xviii–xxiv. 7 indexed citations

16.

Verstappen, Suzanne, J. W. J. Bijlsma, Harry Verkleij, et al.. (2004). Overview of work disability in rheumatoid arthritis patients as observed in cross‐sectional and longitudinal surveys. Arthritis Care & Research. 51(3). 488–497. 171 indexed citations

17.

Putte, L.B.A. van de, Catherine Atkin, Michel Malaise, et al.. (2004). Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed. Annals of the Rheumatic Diseases. 63(5). 508–516. 512 indexed citations breakdown →

18.

Breebaart, A. C., J. W. J. Bijlsma, & Willem van Eden. (2002). 16-year remission of rheumatoid arthritis after unusually vigorous treatment of closed dental foci.. PubMed. 20(4). 555–7. 6 indexed citations

19.

Jacobs, Johannes W G, R. N. J. de Nijs, Willem F. Lems, & J. W. J. Bijlsma. (2000). Bone metabolism in rheumatoid arthritis. Clinical and Experimental Rheumatology. 18. 10 indexed citations

20.

DeGroot, Jeroen, Nicole Verzijl, Ruud A. Bank, et al.. (1999). Age-related decrease in proteoglycan synthesis of human articular chondrocytes: The role of nonenzymatic glycation. Arthritis & Rheumatism. 42(5). 1003–1009. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact